CYX Calyx Ventures Inc

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or the "Company") is pleased
to announce that PGF Biofuels Ltd. ("PGF"), in conjunction with Paterson Grain
and the RSB Services Foundation, has received Roundtable on Sustainable
Biomaterials ("RSB") certification for Resonance(R)carinata. PGF is the first
Canadian organization and only the fourth feedstock provider globally to obtain
this distinguished certification.PGF has partnered with Agrisoma Biosciences
Inc. ("Agrisoma") on the commercialization and market development for
Resonance(R) carinata. Calyx holds an approximately 50% interest in Agrisoma. 


RSB Services Foundation is the implementing entity of the RSB. The RSB is one of
the world's most respected authorities on biomaterial sustainability. Achieving
RSB certification means that PGF has met the stringent international
sustainability standards, encompassing environmental, social and economic
criteria.


Carinata is an oilseed crop well adapted to production in semi-arid regions with
an oil profile ideally suited for use in the renewable aviation and biodiesel
fuel industries.


"We are very pleased that PGF has obtained RSB certification for carinata,"
commented Don Konantz, Chief Executive Officer of Calyx. "This is a very
significant third-party validation for carinata as a biofuel feedstock that will
present significant new opportunities and establish a competitive advantage for
this crop."


Mr. Andrew B. Paterson, Chief Executive Officer of PGF, commented, "RSB
certification will now allow us to access a number of global markets for
carinata oil, which can be converted into renewable aviation fuel or biodiesel.
As the airline industry works towards reducing overall greenhouse gas emissions
by 20% by the year 2020 it is using the RSB certification as its standard to
ensure that procured renewable aviation fuel is produced in an environmentally
sustainable manner. PGF Biofuels is continuing to advance development of this
industrial oilseed crop, which has strong genetic properties, and is looking
forward to scaling up production throughout western Canada and the northern
United States."


Mr. Peter Ryus, Chief Executive Officer of RSB Services Foundation, said, "We
strongly believe that new industrial oilseeds, such as brassica carinata, are
the key to a sustainable bio-based future and we are proud to be a part of the
continued development of this unique oilseed."


PGF has partnered with Agrisoma on the commercialization and market development
for carinata under the Resonance(R) brand and is working with Paterson Grain to
contract with local growers for production. These efforts will ensure current
and future demands for renewable aviation fuel and biodiesel are satisfied.
Agrisoma continues to enhance Resonance(R) carinata with a focus on varietal
development, crop protection, product evaluation and agronomic characteristic
enhancements.


Additionally, BDC Capital Inc. ("BDC"), also a shareholder of Agrisoma, has
advanced $1 million to Agrisoma by way of a promissory note ("Note") to further
Agrisoma's business. Concurrently, BDC has extended the maturity date of an
existing promissory note, in the principal amount of $1 million, (together with
all interest payments) from December 7, 2013. Both Notes now mature on March 31,
2014. 


Concurrently, Calyx and BDC have amended certain terms of their shareholders'
agreement with respect to Agrisoma. Included under the amended terms are
provisions allowing for the expansion of Agrisoma's Board of Directors to
include four qualified, independent directors, one of whom shall be Chair of
Agrisoma's board. In addition, material decisions of Agrisoma requiring special
approval have been defined and require the approval of shareholders holding more
than 60% of the issued and outstanding shares of Agrisoma. Further, issuance of
equity securities in Agrisoma now requires approval by Agrisoma's board, whereas
such issuances previously required the consent of BDC and Calyx. Both Calyx and
BDC have a 60-day pre-emptive right with respect to the allotment of any equity
securities proposed to be issued by Agrisoma.


Calyx also announces than an aggregate of 250,000 stock options have been
granted to certain directors of the Company.


About Calyx

Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) is an agricultural technology company
focused on renewable fuels including biojet and biodiesel. Agrisoma Biosciences
Inc., a company in which Calyx is the largest shareholder, is producing a new
proprietary non-food energy feedstock crop, Resonance(R) carinata, which yields
oil that can be refined into fuels that work in existing engines as a 100
percent petroleum substitute. From seed to sky, fuels produced from Resonance(R)
carinata substantially reduce carbon and other harmful emissions, and help to
reduce global petroleum dependence. For further information about Calyx, please
visit www.calyxbio.com. Resonance(R) is a registered trademark of Agrisoma
Biosciences Inc. For more information on PGF, please visit www.pgfbiofuels.com.
For more information on Agrisoma, please visit www.agrisoma.com. 


Forward-Looking Statements: This document contains certain forward-looking
statements concerning Calyx, as well as other expectations, plans, goals,
objectives, information or statements about future events, conditions, or
performance that may constitute "forward-looking statements" or "forward-looking
information" under applicable securities legislation. Such statements or
information involve substantial known and unknown risks and uncertainties,
certain of which are beyond Calyx's control, including the completion of the
Private Placement and the delay or failure to receive regulatory approvals., 


Such forward-looking statements or information are based on a number of
assumptions, which may prove to be incorrect. In addition to other assumptions
identified in this news release, assumptions have been made regarding, among
other things, timing and completion of the Private Placement, the actual use of
proceeds, and the timing of receipt of regulatory approvals. 


Although Calyx believes that the expectations reflected in such forward-looking
statements or information are reasonable, undue reliance should not be placed on
forward-looking statements because Calyx can give no assurance that such
expectations will prove to be correct. Forward-looking statements or information
are based on current expectations, estimates and projections that involve a
number of risks and uncertainties which could cause actual results to differ
materially from those anticipated by Calyx and described in the forward-looking
statements or information.


The forward-looking statements or information contained in this news release are
made as of the date hereof and Calyx undertakes no obligation to update publicly
or revise any forward-looking statements or information, whether as a result of
new information, future events or otherwise unless so required by applicable
securities laws or the TSX Venture Exchange. The forward-looking statements or
information contained in this news release are expressly qualified by this
cautionary statement.


This press release shall not constitute an offer to sell, nor the solicitation
of an offer to buy, any securities in the United States, nor shall there be any
sale of securities mentioned in this press release in any state in the United
States in which such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such state.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Don Konantz
President & CEO
604-649-5961
604-649-5961


Investor Relations:
Keir Reynolds
778-998-9242
kreynolds@calyxbio.com
www.calyxbio.com

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From Apr 2024 to May 2024

Calyx Ventures (TSXV:CYX)
Historical Stock Chart
From May 2023 to May 2024